Neuronal circuitry underlying the impact of D3 receptor ligands in drug addiction

European Neuropsychopharmacology

Volumn 25, Issue 9, 2015, Pages 1401-1409

  Le Foll, Bernard ^a,b,c   Di Ciano, Patricia ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Accumbens; Addiction; Amygdala; Dopamine; Stimulus; Striatum

Indexed keywords

DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; LIGAND; DOPAMINE RECEPTOR STIMULATING AGENT;

ADVERSE DRUG REACTION; ARTICLE; CONNECTOME; DRUG EFFECT; DRUG SEEKING BEHAVIOR; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECEPTOR DENSITY; REINFORCEMENT; ANIMAL; BRAIN; DRUG EFFECTS; HUMAN; METABOLISM; NERVE TRACT; PHYSIOLOGY; SUBSTANCE-RELATED DISORDERS;

ANIMALS; BRAIN; DOPAMINE AGENTS; DRUG-SEEKING BEHAVIOR; HUMANS; NEURAL PATHWAYS; RECEPTORS, DOPAMINE D3; SUBSTANCE-RELATED DISORDERS;

EID: 84941317804     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2014.08.017     Document Type: Article

References (101)

1. Achat-Mendes C., Grundt P., Cao J., Platt D.M., Newman A.H., Spealman R.D. Dopamine D3 and D2 receptor mechanisms in the abuse-related behavioral effects of cocaine: studies with preferential antagonists in squirrel monkeys. J. Pharmacol. Exp. Ther. 2010, 334:556-565.
2. Andreoli M., Tessari M., Pilla M., Valerio E., Hagan J.J., Heidbreder C.A. Selective antagonism at dopamine D3 receptors prevents nicotine-triggered relapse to nicotine-seeking behavior. Neuropsychopharmacology 2003, 28:1272-1280.
3. Aragona B.J., Cleaveland N.A., Stuber G.D., Day J.J., Carelli R.M., Wightman R.M. Preferential enhancement of dopamine transmission within the nucleus accumbens shell by cocaine is attributable to a direct increase in phasic dopamine release events. J. Neurosci. 2008, 28:8821-8831.
4. Ashby C.R., Paul M., Gardner E.L., Heidbreder C.A., Hagan J.J. Acute administration of the selective D3 receptor antagonist SB-277011A blocks the acquisition and expression of the conditioned place preference response to heroin in male rats. Synapse 2003, 48:154-156.
5. Aujla H., Beninger R.J. Intra-BLA or intra-NAc infusions of the dopamine D3 receptor partial agonist, BP 897, block intra-NAc amphetamine conditioned activity. Behav. Neurosci. 2004, 118:1324-1330.
6. Blaylock B.L., Gould R.W., Banala A., Grundt P., Luedtke R.R., Newman A.H., Nader M.A. Influence of cocaine history on the behavioral effects of dopamine D(3) receptor-selective compounds in monkeys. Neuropsychopharmacology 2011, 36:1104-1113.
7. Boileau I., Payer D., Houle S., Behzadi A., Rusjan P.M., Tong J., Wilkins D., Selby P., George T.P., Zack M., Furukawa Y., McCluskey T., Wilson A.A., Kish S.J. Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study. J. Neurosci. 2012, 32:1353-1359.
8. Bossert J.M., Stern A.L., Theberge F.R., Marchant N.J., Wang H.L., Morales M., Shaham Y. Role of projections from ventral medial prefrontal cortex to nucleus accumbens shell in context-induced reinstatement of heroin seeking. J. Neurosci. 2012, 32:4982-4991.
9. Bouthenet M.L., Souil E., Martres M.P., Sokoloff P., Giros B., Schwartz J.C. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res. 1991, 564:203-219.
10. Breiter H.C., Gollub R.L., Weisskoff R.M., Kennedy D.N., Makris N., Berke J.D., Goodman J.M., Kantor H.L., Gastfriend D.R., Riorden J.P., Mathew R.T., Rosen B.R., Hyman S.E. Acute effects of cocaine on human brain activity and emotion. Neuron 1997, 19:591-611.
11. Brennan K.A., Carati C., Lea R.A., Fitzmaurice P.S., Schenk S. Effect of D1-like and D2-like receptor antagonists on methamphetamine and 3,4-methylenedioxymethamphetamine self-administration in rats. Behav. Pharmacol. 2009, 20:688-694.
12. Brown E.E., Robertson G.S., Fibiger H.C. Evidence for conditional neuronal activation following exposure to a cocaine-paired environment: role of forebrain limbic structures. J. Neurosci. 1992, 12:4112-4121.
13. Cervo L., Burbassi S., Colovic M., Caccia S. Selective antagonist at D3 receptors, but not non-selective partial agonists, influences the expression of cocaine-induced conditioned place preference in free-feeding rats. Pharmacol. Biochem. Behav. 2005, 82:727-734.
14. Cervo L., Carnovali F., Stark J.A., Mennini T. Cocaine-seeking behavior in response to drug-associated stimuli in rats: involvement of D3 and D2 dopamine receptors. Neuropsychopharmacology 2003, 28:1150-1159.
15. Chen Y.I., Famous K., Xu H., Choi J.K., Mandeville J.B., Schmidt H.D., Pierce R.C., Jenkins B.G. Cocaine self-administration leads to alterations in temporal responses to cocaine challenge in limbic and motor circuitry. Eur. J. Neurosci. 2011, 34:800-815.
16. Childress A.R., Mozley P.D., McElgin W., Fitzgerald J., Reivich M., O'Brien C.P. Limbic activation during cue-induced cocaine craving. Am. J. Psychiatry 1999, 156:11-18.
17. Choi J.K., Mandeville J.B., Chen Y.I., Grundt P., Sarkar S.K., Newman A.H., Jenkins B.G. Imaging brain regional and cortical laminar effects of selective D3 agonists and antagonists. Psychopharmacology 2010, 212:59-72.
18. Cole D.M., Oei N.Y., Soeter R.P., Both S., van Gerven J.M., Rombouts S.A., Beckmann C.F. Dopamine-dependent architecture of cortico-subcortical network connectivity. Cereb. Cortex 2013, 23:1509-1516.
19. Collins G.T., Truong Y.N., Levant B., Chen J., Wang S., Woods J.H. Behavioral sensitization to cocaine in rats: evidence for temporal differences in dopamine D3 and D2 receptor sensitivity. Psychopharmacology 2011, 215:609-620.
20. Conrad K.L., Ford K., Marinelli M., Wolf M.E. Dopamine receptor expression and distribution dynamically change in the rat nucleus accumbens after withdrawal from cocaine self-administration. Neuroscience 2010, 169:182-194.
21. de Wit H., Stewart J. Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology 1981, 75:134-143.
22. Di Ciano P. Drug seeking under a second-order schedule of reinforcement depends on dopamine D3 receptors in the basolateral amygdala. Behav. Neurosci. 2008, 122:129-139.
23. Di Ciano P., Blaha C.D., Phillips A.G. Conditioned changes in dopamine oxidation currents in the nucleus accumbens of rats by stimuli paired with self-administration or yoked-administration of d-amphetamine. Eur. J. Neurosci. 1998, 10:1121-1127.
24. Di Ciano P., Blaha C.D., Phillips A.G. The relation between dopamine oxidation currents in the nucleus accumbens and conditioned increases in motor activity in rats following repeated administration of d-amphetamine or cocaine. Eur. J. Neurosci. 1998, 10:1113-1120.
25. Di Ciano P., Everitt B.J. Dissociable effects of antagonism of NMDA and AMPA/KA receptors in the nucleus accumbens core and shell on cocaine-seeking behavior. Neuropsychopharmacology 2001, 25:341-360.
26. Di Ciano P., Everitt B.J. Reinstatement and spontaneous recovery of cocaine-seeking following extinction and different durations of withdrawal. Behav. Pharmacol. 2002, 13:397-405.
27. Di Ciano P., Everitt B.J. Conditioned reinforcing properties of stimuli paired with self-administered cocaine, heroin or sucrose: implications for the persistence of addictive behaviour. Neuropharmacology 2004, 47(Suppl 1):S202-S213.
28. Di Ciano P., Everitt B.J. Direct interactions between the basolateral amygdala and nucleus accumbens core underlie cocaine-seeking behavior by rats. J. Neurosci. 2004, 24:7167-7173.
29. Di Ciano P., Underwood R.J., Hagan J.J., Everitt B.J. Attenuation of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-A. Neuropsychopharmacology 2003, 28:329-338.
30. Diaz J., Pilon C., Le Foll B., Gros C., Triller A., Schwartz J.C., Sokoloff P. Dopamine D3 receptors expressed by all mesencephalic dopamine neurons. J. Neurosci. 2000, 20:8677-8684.
31. Duarte C., Lefebvre C., Chaperon F., Hamon M., Thiebot M.H. Effects of a dopamine D3 receptor ligand, BP 897, on acquisition and expression of food-, morphine-, and cocaine-induced conditioned place preference, and food-seeking behavior in rats. Neuropsychopharmacology 2003, 28:1903-1915.
32. Ehrman R.N., Robbins S.J., Childress A.R., O'Brien C.P. Conditioned responses to cocaine-related stimuli in cocaine abuse patients. Psychopharmacology 1992, 107:523-529.
33. Epstein D.H., Preston K.L. The reinstatement model and relapse prevention: a clinical perspective. Psychopharmacology 2003, 168:31-41.
34. Everitt B.J., Robbins T.W. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci. 2005, 8:1481-1489.
35. Fowler C.D., Lu Q., Johnson P.M., Marks M.J., Kenny P.J. Habenular alpha5 nicotinic receptor subunit signalling controls nicotine intake. Nature 2011, 471:597-601.
36. Frances H., Le Foll B., Diaz J., Smirnova M., Sokoloff P. Role of DRD3 in morphine-induced conditioned place preference using drd3-knockout mice. Neuroreport 2004, 15:2245-2249.
37. Frances H., Smirnova M., Leriche L., Sokoloff P. Dopamine D3 receptor ligands modulate the acquisition of morphine-conditioned place preference. Psychopharmacology 2004, 175:127-133.
38. Gal K., Gyertyan I. Dopamine D3 as well as D2 receptor ligands attenuate the cue-induced cocaine-seeking in a relapse model in rats. Drug Alcohol Depend. 2006, 81:63-70.
39. Gilbert J.G., Newman A.H., Gardner E.L., Ashby C.R., Heidbreder C.A., Pak A.C., Peng X.Q., Xi Z.X. Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D(3) receptors. Synapse 2005, 57:17-28.
40. Glickstein S.B., Desteno D.A., Hof P.R., Schmauss C. Mice lacking dopamine D2 and D3 receptors exhibit differential activation of prefrontal cortical neurons during tasks requiring attention. Cereb. Cortex 2005, 15:1016-1024.
41. Goldberg S.R., Kelleher R.T. Behavior controlled by scheduled injections of cocaine in squirrel and rhesus monkeys. J. Exp. Anal. Behav. 1976, 25:93-104.
42. Goldberg S.R., Kelleher R.T., Morse W.H. Second-order schedules of drug injection. Fed. Proc. 1975, 34:1771-1776.
43. Gratton A., Wise R.A. Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous cocaine self-administration in rats. J. Neurosci. 1994, 14:4130-4146.
44. Grimm J.W., Hope B.T., Wise R.A., Shaham Y. Neuroadaptation. Incubation of cocaine craving after withdrawal. Nature 2001, 412:141-142.
45. Gurevich E.V., Joyce J.N. Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons. Neuropsychopharmacology 1999, 20:60-80.
46. Gyertyan I., Gal K. Dopamine D3 receptor ligands show place conditioning effect but do not influence cocaine-induced place preference. Neuroreport 2003, 14:93-98.
47. Heidbreder C. Novel pharmacotherapeutic targets for the management of drug addiction. Eur. J. Pharmacol. 2005, 526:101-112.
48. Heidbreder C.A., Andreoli M., Marcon C., Hutcheson D.M., Gardner E.L., Ashby C.R. Evidence for the role of dopamine D3 receptors in oral operant alcohol self-administration and reinstatement of alcohol-seeking behavior in mice. Addict. Biol. 2007, 12:35-50.
49. Hemby S.E., Smith J.E., Dworkin S.I. The effects of eticlopride and naltrexone on responding maintained by food, cocaine, heroin and cocaine/heroin combinations in rats. J. Pharmacol. Exp. Ther. 1996, 277:1247-1258.
50. Higley A.E., Kiefer S.W., Li X., Gaal J., Xi Z.X., Gardner E.L. Dopamine D(3) receptor antagonist SB-277011A inhibits methamphetamine self-administration and methamphetamine-induced reinstatement of drug-seeking in rats. Eur. J. Pharmacol. 2012, 659:187-192.
51. Higley A.E., Spiller K., Grundt P., Newman A.H., Kiefer S.W., Xi Z.X., Gardner E.L. PG01037, a novel dopamine D3 receptor antagonist, inhibits the effects of methamphetamine in rats. J. Psychopharmacol. 2011, 25:263-273.
52. Hitchcott P.K., Phillips G.D. Effects of intra-amygdala R(+) 7-OH-DPAT on intra-accumbens d- amphetamine-associated learning. II. Instrumental conditioning. Psychopharmacology 1998, 140:310-318.
53. Hondo H., Spitzer R.H., Grinius B., Richtand N.M. Quantification of dopamine D3 receptor mRNA level associated with the development of amphetamine-induced behavioral sensitization in the rat brain. Neurosci. Lett. 1999, 264:69-72.
54. Ito R., Dalley J.W., Howes S.R., Robbins T.W., Everitt B.J. Dissociation in conditioned dopamine release in the nucleus accumbens core and shell in response to cocaine cues and during cocaine-seeking behavior in rats. J. Neurosci. 2000, 20:7489-7495.
55. Khaled M., Pushparaj A., Di Ciano P., Diaz J., Le foll B. Dopamine D3 receptors in the basolateral amygdala and the lateral habenula modulate cue-induced reinstatement of nicotine-seeking. Neuropsychopharmacology 2014, http://dx.doi.org/10.1038/npp.2014.158, in press.
56. Khaled M.A., Farid Araki K., Li B., Coen K.M., Marinelli P.W., Varga J., Gaal J., Le Foll B. The selective dopamine D3 receptor antagonist SB 277011-A, but not the partial agonist BP 897, blocks cue-induced reinstatement of nicotine-seeking. Int. J. Neuropsychopharmacol. 2010, 13:181-190.
57. Kolasiewicz W., Maj J., Ossowska K. The involvement of cerebellar dopamine D3 receptors in locomotor activity of rats. J. Neural Transm. 2008, 115:677-681.
58. Le Foll B., Diaz J., Sokoloff P. Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats. Synapse 2003, 47:176-183.
59. Le Foll B., Diaz J., Sokoloff P. Neuroadaptations to hyperdopaminergia in dopamine D3 receptor-deficient mice. Life Sci. 2005, 76:1281-1296.
60. Le Foll B., Diaz J., Sokoloff P. A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning. Neuroreport 2005, 16:175-178.
61. Le Foll B., Frances H., Diaz J., Schwartz J.C., Sokoloff P. Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice. Eur. J. Neurosci. 2002, 15:2016-2026.
62. Le Foll B., Goldberg S.R., Sokoloff P. The dopamine D3 receptor and drug dependence: effects on reward or beyond?. Neuropharmacology 2005, 49:525-541.
63. Le Foll B., Schwartz J.C., Sokoloff P. Disruption of nicotine conditioning by dopamine D(3) receptor ligands. Mol. Psychiatry 2003, 8:225-230.
64. Leggio G.M., Camillieri G., Platania C.B., Castorina A., Marrazzo G., Torrisi S.A., Nona C.N., D'Agata V., Nobrega J., Stark H., Bucolo C., Le Foll B., Drago F., Salomone S. Dopamine d3 receptor is necessary for ethanol consumption: an approach with buspirone. Neuropsychopharmacology 2014, 39:2017-2028.
65. Liang J., Zheng X., Chen J., Li Y., Xing X., Bai Y. Roles of BDNF, dopamine D(3) receptors, and their interactions in the expression of morphine-induced context-specific locomotor sensitization. Eur. Neuropsychopharmacol. 2011, 21:825-834.
66. Matsumoto M., Hikosaka O. Lateral habenula as a source of negative reward signals in dopamine neurons. Nature 2007, 447:1111-1115.
67. McCormick P.N., Wilson V.S., Wilson A.A., Remington G.J. Acutely administered antipsychotic drugs are highly selective for dopamine D2 over D3 receptors. Pharmacol. Res. 2013, 70:66-71.
68. Neisewander J.L., Fuchs R.A., Tran-Nguyen L.T., Weber S.M., Coffey G.P., Joyce J.N. Increases in dopamine D3 receptor binding in rats receiving a cocaine challenge at various time points after cocaine self-administration: implications for cocaine-seeking behavior. Neuropsychopharmacology 2004, 29:1479-1487.
69. Neisewander J.L., O'Dell L.E., Tran-Nguyen L.T., Castaneda E., Fuchs R.A. Dopamine overflow in the nucleus accumbens during extinction and reinstatement of cocaine self-administration behavior. Neuropsychopharmacology 1996, 15:506-514.
70. Orio L., Wee S., Newman A.H., Pulvirenti L., Koob G.F. The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access. Addict. Biol. 2010, 15:312-323.
71. Pak A.C., Ashby C.R., Heidbreder C.A., Pilla M., Gilbert J., Xi Z.X., Gardner E.L. The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions. Int. J. Neuropsychopharmacol. 2006, 9:585-602.
72. Parkinson J.A., Olmstead M.C., Burns L.H., Robbins T.W., Everitt B.J. Dissociation in effects of lesions of the nucleus accumbens core and shell on appetitive Pavlovian approach behavior and the potentiation of conditioned reinforcement and locomotor activity by d-amphetamine. J. Neurosci. 1999, 19:2401-2411.
73. Parsons L.H., Caine S.B., Sokoloff P., Schwartz J.C., Koob G.F., Weiss F. Neurochemical evidence that postsynaptic nucleus accumbens D3 receptor stimulation enhances cocaine reinforcement. J. Neurochem. 1996, 67:1078-1089.
74. Pickens C.L., Airavaara M., Theberge F., Fanous S., Hope B.T., Shaham Y. Neurobiology of the incubation of drug craving. Trends Neurosci. 2011, 34:411-420.
75. Pilla M., Perachon S., Sautel F., Garrido F., Mann A., Wermuth C.G., Schwartz J.C., Everitt B.J., Sokoloff P. Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature 1999, 400:371-375.
76. Reavill C., Taylor S.G., Wood M.D., Ashmeade T., Austin N.E., Avenell K.Y., Boyfield I., Branch C.L., Cilia J., Coldwell M.C., Hadley M.S., Hunter A.J., Jeffrey P., Jewitt F., Johnson C.N., Jones D.N., Medhurst A.D., Middlemiss D.N., Nash D.J., Riley G.J., Routledge C., Stemp G., Thewlis K.M., Trail B., Vong A.K., Hagan J.J. Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A. J. Pharmacol. Exp. Ther. 2000, 294:1154-1165.
77. Roberts C., Cummins R., Gnoffo Z., Kew J.N. Dopamine D3 receptor modulation of dopamine efflux in the rat nucleus accumbens. Eur. J. Pharmacol. 2006, 534:108-114.
78. Schmidt H.D., Anderson S.M., Pierce R.C. Stimulation of D1-like or D2 dopamine receptors in the shell, but not the core, of the nucleus accumbens reinstates cocaine-seeking behaviour in the rat. Eur. J. Neurosci. 2006, 23:219-228.
79. Schultz W. Predictive reward signal of dopamine neurons. J. Neurophysiol. 1998, 80:1-27.
80. Schwarz A., Gozzi A., Reese T., Bertani S., Crestan V., Hagan J., Heidbreder C., Bifone A. Selective dopamine D(3) receptor antagonist SB-277011-A potentiates phMRI response to acute amphetamine challenge in the rat brain. Synapse 2004, 54:1-10.
81. Segal D.M., Moraes C.T., Mash D.C. Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities. Brain Res. Mol. Brain Res. 1997, 45:335-339.
82. Shimizu S., Tatara A., Sato M., Sugiuchi T., Miyoshi S., Andatsu S., Kizu T., Ohno Y. Role of cerebellar dopamine D(3) receptors in modulating exploratory locomotion and cataleptogenicity in rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 2014, 50:157-162.
83. Sibley D.R., Monsma F.J. Molecular biology of dopamine receptors. Trends Pharmacol. Sci. 1992, 13:61-69.
84. Sokoloff P., Giros B., Martres M.P., Bouthenet M.L., Schwartz J.C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 1990, 347:146-151.
85. Song R., Yang R.F., Wu N., Su R.B., Li J., Peng X.Q., Li X., Gaal J., Xi Z.X., Gardner E.L. YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D3 receptor-knockout mice. Addict. Biol. 2012, 17:259-273.
86. Southam E., Lloyd A., Jennings C.A., Cluderay J.E., Cilia J., Gartlon J.E., Jones D.N. Effect of the selective dopamine D3 receptor antagonist SB-277011-A on regional c-Fos-like expression in rat forebrain. Brain Res. 2007, 1149:50-57.
87. Spiller K., Xi Z.X., Peng X.Q., Newman A.H., Ashby C.R., Heidbreder C., Gaal J., Gardner E.L. The selective dopamine D3 receptor antagonists SB-277011A and NGB 2904 and the putative partial D3 receptor agonist BP-897 attenuate methamphetamine-enhanced brain stimulation reward in rats. Psychopharmacol. 2008, 196:533-542.
88. Staley J.K., Mash D.C. Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities. J. Neurosci. 1996, 16:6100-6106.
89. Stanwood G.D., Lucki I., McGonigle P. Differential regulation of dopamine D2 and D3 receptors by chronic drug treatments. J. Pharmacol. Exp. Ther. 2000, 295:1232-1240.
90. Suzuki M., Hurd Y.L., Sokoloff P., Schwartz J.C., Sedvall G. D3 dopamine receptor mRNA is widely expressed in the human brain. Brain Res. 1998, 779:58-74.
91. Thanos P.K., Michaelides M., Ho C.W., Wang G.J., Newman A.H., Heidbreder C.A., Ashby C.R., Gardner E.L., Volkow N.D. The effects of two highly selective dopamine D3 receptor antagonists (SB-277011A and NGB-2904) on food self-administration in a rodent model of obesity. Pharmacol. Biochem. Behav. 2008, 89:499-507.
92. Thiel K.J., Wenzel J.M., Pentkowski N.S., Hobbs R.J., Alleweireldt A.T., Neisewander J.L. Stimulation of dopamine D2/D3 but not D1 receptors in the central amygdala decreases cocaine-seeking behavior. Behav. Brain Res. 2010, 214:386-394.
93. Vanderschuren L.J., Di Ciano P., Everitt B.J. Involvement of the dorsal striatum in cue-controlled cocaine seeking. J. Neurosci. 2005, 25:8665-8670.
94. Vengeliene V., Leonardi-Essmann F., Perreau-Lenz S., Gebicke-Haerter P., Drescher K., Gross G., Spanagel R. The dopamine D3 receptor plays an essential role in alcohol-seeking and relapse. FASEB J. 2006, 20:2223-2233.
95. Vorel S.R., Ashby C.R., Paul M., Liu X., Hayes R., Hagan J.J., Middlemiss D.N., Stemp G., Gardner E.L. Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J. Neurosci. 2002, 22:9595-9603.
96. Woolverton W.L. Effects of a D1 and a D2 dopamine antagonist on the self-administration of cocaine and piribedil by rhesus monkeys. Pharmacol. Biochem. Behav. 1986, 24:531-535.
97. Xi Z.X., Gilbert J., Campos A.C., Kline N., Ashby C.R., Hagan J.J., Heidbreder C.A., Gardner E.L. Blockade of mesolimbic dopamine D(3) receptors inhibits stress-induced reinstatement of cocaine-seeking in rats. Psychopharmacology 2004, 176:57-65.
98. Xi Z.X., Gilbert J.G., Pak A.C., Ashby C.R., Heidbreder C.A., Gardner E.L. Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost-variable-payoff fixed-ratio cocaine self-administration in rats. Eur. J. Neurosci. 2005, 21:3427-3438.
99. Xi Z.X., Li X., Li J., Peng X.Q., Song R., Gaal J., Gardner E.L. Blockade of dopamine D3 receptors in the nucleus accumbens and central amygdala inhibits incubation of cocaine craving in rats. Addict. Biol. 2013, 18:665-677.
100. Yokel R.A., Wise R.A. Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward. Science 1975, 187:547-549.
101. Zapata A., Shippenberg T.S. D(3) receptor ligands modulate extracellular dopamine clearance in the nucleus accumbens. J. Neurochem. 2002, 81:1035-1042.